<?xml version="1.0" encoding="UTF-8"?>
<datei>
  <row>
    <publishedID>56437</publishedID>
    <Artikel>18F-Tagged inhibitors of prostate specific membrane anatigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer</Artikel>
    <PubYear>2014</PubYear>
    <Author Pos="0" name="Bauder-Wuest" IsDKFZ="1"/>
    <Author Pos="1" name="Benesova" IsDKFZ="1"/>
    <Author Pos="2" name="Cardinale" IsDKFZ="1"/>
    <Author Pos="3" name="Eisenhut" IsDKFZ="1"/>
    <Author Pos="4" name="Haberkorn" IsDKFZ="1"/>
    <Author Pos="5" name="Kopka" IsDKFZ="1"/>
    <Author Pos="6" name="SchÃ¤fer" IsDKFZ="1"/>
    <Author Pos="7" name="Eder" IsDKFZ="1"/>
    <PatNum>1 400 357 0.0</PatNum>
    <KST>x</KST>
    <KST>xx</KST>
    <KST>xxx</KST>
    <Prog>Krebsforschung</Prog>
  </row>
</datei>
